相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A review of glioblastoma immunotherapy
Ravi Medikonda et al.
JOURNAL OF NEURO-ONCOLOGY (2021)
Molecular Mechanisms of Treatment Resistance in Glioblastoma
Alexander Ou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Neuroinvasion of SARS-CoV-2 in human and mouse brain
Eric Song et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19
Jenny Meinhardt et al.
NATURE NEUROSCIENCE (2021)
No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor
Jarrod Shilts et al.
SCIENTIFIC REPORTS (2021)
The Role of Temozolomide in Patients With Newly Diagnosed Wild-Type IDH, Unmethylated MGMTp Glioblastoma During the COVID-19 Pandemic
David O. Kamson et al.
JAMA ONCOLOGY (2021)
mRNA vaccine for cancer immunotherapy
Lei Miao et al.
MOLECULAR CANCER (2021)
Immunotherapy of Glioblastoma: Current Strategies and Challenges in Tumor Model Development
Bernarda Majc et al.
CELLS (2021)
Regulation of MHC I Molecules in Glioblastoma Cells and the Sensitizing of NK Cells
Timo Burster et al.
PHARMACEUTICALS (2021)
Susceptibility of neuroblastoma and glioblastoma cell lines to SARS-CoV-2 infection
Valery Bielarz et al.
BRAIN RESEARCH (2021)
Overcoming delivery barriers in immunotherapy for glioblastoma
Yuan Rui et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2021)
The provision of neuro-oncology and glioma neurosurgery during the SARS-CoV-2 pandemic: a single national tertiary centre experience
Michael Amoo et al.
IRISH JOURNAL OF MEDICAL SCIENCE (2021)
Insights in the immunobiology of glioblastoma
Dimitrios Strepkos et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2020)
The challenge and prospect of mRNA therapeutics landscape
Yuhua Weng et al.
BIOTECHNOLOGY ADVANCES (2020)
Outer Radial Glia-like Cancer Stem Cells Contribute to Heterogeneity of Glioblastoma
Aparna Bhaduri et al.
CELL STEM CELL (2020)
Potential of Glioblastoma-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy
Ryan D. Salinas et al.
CNS DRUGS (2020)
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
Michael Letko et al.
NATURE MICROBIOLOGY (2020)
Resistance Mechanisms and Barriers to Successful Immunotherapy for Treating Glioblastoma
Jason Adhikaree et al.
CELLS (2020)
O6-Methylguanine-DNA Methyltransferase (MGMT): Challenges and New Opportunities in Glioma Chemotherapy
Wei Yu et al.
FRONTIERS IN ONCOLOGY (2020)
Tumor mutational burden is associated with poor outcomes in diffuse glioma
Lihong Wang et al.
BMC CANCER (2020)
Aiming at the tumor-specific accumulation of MGMT-inhibitors: First description of a synthetic strategy towards inhibitor-peptide conjugates
Bjoern Waengler et al.
TETRAHEDRON LETTERS (2020)
Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity
Christina A. von Roemeling et al.
NATURE COMMUNICATIONS (2020)
Neurotropism of SARS-CoV 2: Mechanisms and manifestations
Giancarlos Conde Cardona et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China
Ling Mao et al.
JAMA NEUROLOGY (2020)
Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma
Bhavesh K. Ahir et al.
MOLECULAR NEUROBIOLOGY (2020)
Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives
Bas Weenink et al.
CANCERS (2020)
Neuro-oncology management during the COVID-19 pandemic with a focus on WHO grades III and IV gliomas
Denise Bernhardt et al.
NEURO-ONCOLOGY (2020)
Multiorgan and Renal Tropism of SARS-CoV-2
Victor G. Puelles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Once, Twice, Three Times a Finding: Reproducibility of Dendritic Cell Vaccine Trials Targeting Cytomegalovirus in Glioblastoma
Kristen A. Batich et al.
CLINICAL CANCER RESEARCH (2020)
Tumor markers as an entry for SARS-CoV-2 infection?
Pu Xia et al.
FEBS JOURNAL (2020)
Exploiting the Complexities of Glioblastoma Stem Cells: Insights for Cancer Initiation and Therapeutic Targeting
Joana Vieira de Castro et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Epigenetic Targeting of Mcl-1 Is Synthetically Lethal with Bcl-xL/Bcl-2 Inhibition in Model Systems of Glioblastoma
Enyuan Shang et al.
CANCERS (2020)
Comment in Response to Temozolomide in Glioblastoma Therapy: Role of Apoptosis, Senescence and Autophagy etc. by B. Kaina
Mike-Andrew Westhoff et al.
BIOMEDICINES (2020)
Considering the Experimental Use of Temozolomide in Glioblastoma Research
Verena J. Herbener et al.
BIOMEDICINES (2020)
Early postmortem brain MRI findings in COVID-19 non-survivors
Tim Coolen et al.
NEUROLOGY (2020)
Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas
Qing Zhang et al.
CELL DEATH & DISEASE (2020)
Treatment of patients with glioma during the COVID-19 pandemic: what we learned and what we take home for the future
Federico Pessina et al.
NEUROSURGICAL FOCUS (2020)
Single-Cell Sequencing of Glioblastoma Reveals Central Nervous System Susceptibility to SARS-CoV-2
Bingshan Wu et al.
FRONTIERS IN ONCOLOGY (2020)
Radiation for Glioblastoma in the Era of Coronavirus Disease 2019 (COVID-19): Patient Selection and Hypofractionation to Maximize Benefit and Minimize Risk
Sonal S. Noticewala et al.
ADVANCES IN RADIATION ONCOLOGY (2020)
Role of stem cell mobilization in the treatment of ischemic diseases
Seong Gyu Kwon et al.
ARCHIVES OF PHARMACAL RESEARCH (2019)
Glioblastoma cancer stem cell biology: Potential theranostic targets
Farzaneh Sharifzad et al.
DRUG RESISTANCE UPDATES (2019)
Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients
Denis Migliorini et al.
NEURO-ONCOLOGY (2019)
Combined inhibition of RAC1 and Bcl-2/Bcl-xL synergistically induces glioblastoma cell death through down-regulation of the Usp9X/Mcl-1 axis
Michal Hlavac et al.
CELLULAR ONCOLOGY (2019)
Glioblastoma vs temozolomide: can the red queen race be won?
Anjali Arora et al.
CANCER BIOLOGY & THERAPY (2019)
A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma
Patrick Y. Wen et al.
CLINICAL CANCER RESEARCH (2019)
Mechanisms of immunotherapy resistance: lessons from glioblastoma
Christopher M. Jackson et al.
NATURE IMMUNOLOGY (2019)
Activation of LXRβ inhibits tumor respiration and is synthetically lethal with Bcl-xL inhibition
Trang Thi Thu Nguyen et al.
EMBO MOLECULAR MEDICINE (2019)
Neoantigen vaccine: an emerging tumor immunotherapy
Miao Peng et al.
MOLECULAR CANCER (2019)
Molecular targeted therapy of glioblastoma
Emilie Le Rhun et al.
CANCER TREATMENT REVIEWS (2019)
CD147 Is a Promising Target of Tumor Progression and a Prognostic Biomarker
Alexandra Landras et al.
CANCERS (2019)
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin et al.
NATURE (2019)
Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins
Rumani Singh et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
On the Critical Issues in Temozolomide Research in Glioblastoma: Clinically Relevant Concentrations and MGMT-independent Resistance
Aleksei A. Stepanenko et al.
BIOMEDICINES (2019)
Temozolomide in Glioblastoma Therapy: Role of Apoptosis, Senescence and Autophagy. Comment on Strobel et al., Temozolomide and Other Alkylating Agents in Glioblastoma Therapy. Biomedicines 2019, 7, 69
Bernd Kaina
BIOMEDICINES (2019)
Temozolomide and Other Alkylating Agents in Glioblastoma Therapy
Hannah Strobel et al.
BIOMEDICINES (2019)
Advances in immunotherapeutic research for glioma therapy
Jeremy Tetsuo Miyauchi et al.
JOURNAL OF NEUROLOGY (2018)
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
Linda M. Liau et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Current state of immunotherapy for glioblastoma
Michael Lim et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
mRNA vaccines - a new era in vaccinology
Norbert Pardi et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Temozolomide for immunomodulation in the treatment of glioblastoma
Aida Karachi et al.
NEURO-ONCOLOGY (2018)
Natural products: a hope for glioblastoma patients
Raghupathy Vengoji et al.
Oncotarget (2018)
Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas
Yibo Yin et al.
MOLECULAR THERAPY-ONCOLYTICS (2018)
MCL-1 inhibition in cancer treatment
Weiguo Xiang et al.
ONCOTARGETS AND THERAPY (2018)
Sensitization of glioblastoma cells to TRAIL-induced apoptosis by IAP- and Bcl-2 antagonism
Frank A. Lincoln et al.
CELL DEATH & DISEASE (2018)
Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia
Adriana E. Tron et al.
NATURE COMMUNICATIONS (2018)
Current State of Dendritic Cell-Based Immunotherapy: Opportunities for in vitro Antigen Loading of Different DC Subsets?
Anne Huber et al.
FRONTIERS IN IMMUNOLOGY (2018)
Immune checkpoint inhibitors: recent progress and potential biomarkers
Pramod Darvin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Immunotherapy Approaches in the Treatment of Malignant Brain Tumors
Anastasie M. Dunn-Pirio et al.
CANCER (2017)
Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas
Jennifer E. Kim et al.
CLINICAL CANCER RESEARCH (2017)
Immune microenvironment of gliomas
Anna Gieryng et al.
LABORATORY INVESTIGATION (2017)
Antibody-drug conjugates in glioblastoma therapy: the right drugs to the right cells
Hui K. Gan et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy
Tiffany R. Hodges et al.
NEURO-ONCOLOGY (2017)
Blockade of CCR5 receptor prevents M2 microglia phenotype in a microglia-glioma paradigm
Emilia Laudati et al.
NEUROCHEMISTRY INTERNATIONAL (2017)
Oncolytic Virotherapy for the Treatment of Malignant Glioma
Paul M. Foreman et al.
NEUROTHERAPEUTICS (2017)
Induction of synthetic lethality in IDH1-mutated gliomas through inhibition of Bcl-xL
Georg Karpel-Massler et al.
NATURE COMMUNICATIONS (2017)
Immune Checkpoint in Glioblastoma: Promising and Challenging
Jing Huang et al.
FRONTIERS IN PHARMACOLOGY (2017)
1057PDFINAL RESULTS FROM A CANCER RESEARCH UK FIRST IN MAN PHASE I TRIAL OF IMA950 (A NOVEL MULTI PEPTIDE VACCINE) PLUS GM-CSF IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
S. Halford et al.
ANNALS OF ONCOLOGY (2017)
Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study
Martin van den Bent et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Overexpression of FADD and Caspase-8 inhibits proliferation and promotes apoptosis of human glioblastoma cells (Publication with Expression of Concern. See vol. 155, 2022) (Publication with Expression of Concern. See vol. 155, 2022)
Hong-Bin Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Cathepsin K cleavage of SDF-1α inhibits its chemotactic activity towards glioblastoma stem-like cells
Vashendriya V. V. Hira et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2017)
The Immune System in Cancer Prevention, Development and Therapy
Serge M. Candeias et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2016)
Adenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of recurrent high-grade glioma
Nan Ji et al.
ONCOTARGET (2016)
CSF1 Overexpression Promotes High-Grade Glioma Formation without Impacting the Polarization Status of Glioma-Associated Microglia and Macrophages
Ishani De et al.
CANCER RESEARCH (2016)
Nitrosoureas in the Management of Malignant Gliomas
Alba A. Brandes et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2016)
Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model
Laura Mercurio et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
ABT-414, an Antibody-Drug Conjugate Targeting a Tumor-Selective EGFR Epitope
Andrew C. Phillips et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Glioblastoma vaccine therapy disappointment in Phase III trial
Hemi Malkki
Nature Reviews Neurology (2016)
Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma
Lee A. Wheeler et al.
NEURO-ONCOLOGY (2016)
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Christine E. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
Sebastien Viel et al.
SCIENCE SIGNALING (2016)
Anti-PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM
Dimitrios Mathios et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
Shohei Koyama et al.
NATURE COMMUNICATIONS (2016)
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
Sebastien Viel et al.
SCIENCE SIGNALING (2016)
ABCG2 regulates self-renewal and stem cell marker expression but not tumorigenicity or radiation resistance of glioma cells
Boyoung Wee et al.
SCIENTIFIC REPORTS (2016)
Patient survival on the dose escalation phase of the Oncolytic Polio/Rhinovirus Recombinant (PVSRIPO) against WHO grade IV malignant glioma (MG) clinical trial compared to historical controls.
Annick Desjardins et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Immune Evasion Strategies of Glioblastoma
Seyed-Mostafa Razavi et al.
FRONTIERS IN SURGERY (2016)
Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype
Konrad Gabrusiewicz et al.
JCI INSIGHT (2016)
PD-1 blockade enhances the vaccination-induced immune response in glioma
Joseph P. Antonios et al.
JCI INSIGHT (2016)
Antibody-drug conjugates as novel anti-cancer chemotherapeutics
Christina Peters et al.
BIOSCIENCE REPORTS (2015)
The Evolution of T-cell Therapies for Solid Malignancies
Kristen Fousek et al.
CLINICAL CANCER RESEARCH (2015)
Apoptosis-related gene expression in tumor tissue samples obtained from patients diagnosed with glioblastoma multiforme
Eva Blahovcova et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2015)
Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
Douglas Marvel et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Heat shock protein vaccines against glioblastoma: from bench to bedside
Leonel Ampie et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study
James Schuster et al.
NEURO-ONCOLOGY (2015)
Cytotoxic and genotoxic effects mediated by M2 muscarinic receptor activation in human glioblastoma cells
Maria Di Bari et al.
NEUROCHEMISTRY INTERNATIONAL (2015)
Preliminary safety and activity of nivolumab and its combination with ipilimumab in recurrent glioblastoma (GBM): CHECKMATE-143.
John H. Sampson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial
Orin Bloch et al.
NEURO-ONCOLOGY (2014)
Targeting adaptive glioblastoma: an overview of proliferation and invasion
Qian Xie et al.
NEURO-ONCOLOGY (2014)
A Systematic Comparison of the Anti-Tumoural Activity and Toxicity of the Three Adv-TKs
Qinglei Gao et al.
PLOS ONE (2014)
DCVax®-L-Developed by Northwest Biotherapeutics
Stavros Polyzoidis et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
GDNF mediates glioblastoma-induced microglia attraction but not astrogliosis
Min-Chi Ku et al.
ACTA NEUROPATHOLOGICA (2013)
Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
Surasak Phuphanich et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
Einar Osland Vik-Mo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Individual Patient-Specific Immunity against High-Grade Glioma after Vaccination with Autologous Tumor Derived Peptides Bound to the 96 KD Chaperone Protein
Courtney A. Crane et al.
CLINICAL CANCER RESEARCH (2013)
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Stephanie M. Pyonteck et al.
NATURE MEDICINE (2013)
Synergistic Effect of CTLA-4 Blockade and Cancer Chemotherapy in the Induction of Anti-Tumor Immunity
W. Joost Lesterhuis et al.
PLOS ONE (2013)
Preclinical Development of a Novel Class of CXCR4 Antagonist Impairing Solid Tumors Growth and Metastases
Luigi Portella et al.
PLOS ONE (2013)
Ipilimumab: a novel immunomodulating therapy causing autoimmune hypophysitis: a case report and review
Agata Juszczak et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
The role of STAT3 activation in modulating the immune microenvironment of GBM
Alfred P. See et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
The Role of Bcl-2 Family Proteins in Therapy Responses of Malignant Astrocytic Gliomas: Bcl2L12 and Beyond
Fotini M. Kouri et al.
SCIENTIFIC WORLD JOURNAL (2012)
Capture, crawl, cross: the T cell code to breach the blood-brain barriers
Britta Engelhardt et al.
TRENDS IN IMMUNOLOGY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Phase IB Study of Gene-Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma
E. Antonio Chiocca et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Role of Bcl-2 family proteins and caspases in the regulation of apoptosis
Mohammad Shamsul Ola et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Lanatoside C sensitizes glioblastoma cells to tumor necrosis factor-related apoptosis-inducing ligand and induces an alternative cell death pathway
Christian E. Badr et al.
NEURO-ONCOLOGY (2011)
Illuminating viral infections in the nervous system
Dorian B. McGavern et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Pseudoprogression or pseudoresponse: a challenge for the diagnostic imaging in Glioblastoma multiforme
Franz Payer
WIENER MEDIZINISCHE WOCHENSCHRIFT (2011)
Glioma cancer stem cells induce immunosuppressive macrophages/microglia
Adam Wu et al.
NEURO-ONCOLOGY (2010)
Antibody-Drug Conjugates for the Treatment of Non-Hodgkin's Lymphoma: Target and Linker-Drug Selection
Andrew G. Polson et al.
CANCER RESEARCH (2009)
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
Trine H. Mogensen
CLINICAL MICROBIOLOGY REVIEWS (2009)
OPINION Chemokine receptor antagonists: overcoming developmental hurdles
Richard Horuk
NATURE REVIEWS DRUG DISCOVERY (2009)
Small-Molecule XIAP Inhibitors Enhance γ-Irradiation-Induced Apoptosis in Glioblastoma
Sriharikrishna Vellanki et al.
NEOPLASIA (2009)
A novel CXCR4 antagonist for hematopoietic stem cell mobilization
Simon P. Fricker
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins
K. E. Tagscherer et al.
ONCOGENE (2008)
A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients
S. Farzana Hussain et al.
CANCER RESEARCH (2007)
The role of versican isoforms V0/V1 in glioma migration mediated by transforming growth factor-β2
F. Arslan et al.
BRITISH JOURNAL OF CANCER (2007)
Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma
Alexander H. Stegh et al.
GENES & DEVELOPMENT (2007)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Mcl-1
J Michels et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Critical upstream signals of cytochrome c release induced by a novel Bcl-2 inhibitor
J An et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Glioblastoma cells release factors that disrupt blood-brain barrier features
SW Schneider et al.
ACTA NEUROPATHOLOGICA (2004)
BCL-2-induced glioma cell invasiveness depends on furin-like proteases
W Wick et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Apoptosis in gliomas: molecular mechanisms and therapeutic implications
JP Steinbach et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Oblimersen sodium (G3139 bcl-2 antisense oligonucleotide) therapy in Waldenstrom's macroglobulinemia: A targeted approach to enhance apoptosis
SR Frankel
SEMINARS IN ONCOLOGY (2003)
Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors:: Consequences for the NK-mediated killing of dendritic cells
R Castriconi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
A functional role of HLA-G expression in human gliomas: An alternative strategy of immune escape
H Wiendl et al.
JOURNAL OF IMMUNOLOGY (2002)
Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells
MJ Knight et al.
ONCOGENE (2001)
Blood-brain barrier genomics
JY Li et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2001)
Antisense-mediated inhibition of the bcl-2 gene induces apoptosis in human malignant glioma
T Julien et al.
SURGICAL NEUROLOGY (2000)
分享论文
